22NW Fund GP, LLC
CIK 1770575 · last filed 2025-12-12
22NW Fund GP, LLC is a corporate insider who has filed 7 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing shows the insider sold $1.3M of FSTR on Dec 12, 2025. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $56.5M across reported positions. The firm reports its address in Seattle, WA. 52 SEC filings were submitted jointly with 22NW Fund, LP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
FSTR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SEATTLE, WA 98107
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FSTR | 10%+ Owner | 1,191,951 | $42.52 | $50.68M | -$2.39M | 4 | 2025-12-12 |
| CULP | 10%+ Owner | 1,621,601 | $3.59 | $5.82M | $367.4K | 2 | 2024-12-20 |
| MERRIMACK PHARMACEUTICALS INC (MACK) Delisted | 10%+ Owner | 1,241,896 | $15.13 | $18.79M | $391.3K | 1 | 2019-04-17 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-12 | FSTR | Sell (S) | −47,537 | -$1.27M | EDGAR |
| 2025-12-10 | FSTR | Sell (S) | −25,813 | -$697.4K | EDGAR |
| 2025-11-18 | FSTR | Sell (S) | −2,647 | -$71.5K | EDGAR |
| 2025-11-13 | FSTR | Sell (S) | −12,530 | -$345.6K | EDGAR |
| 2024-12-20 | CULP | Buy (P) | +13,444 | $70.5K | EDGAR |
| 2024-07-10 | CULP | Buy (P) | +61,373 | $296.9K | EDGAR |
| 2019-04-17 | MERRIMACK PHARMACEUTICALS INC (MACK) Delisted | Buy (P) | +66,760 | $391.3K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.